reactive systemic amyloidosis
The definitions used in this glossary of terminology either have been provided by the authors of the articles, or have been extracted wholly or in part, or paraphrased from the following sources: The American Medical Association Encyclopedia of Medicine, Charles B. Clayman, MD, Medical Editor, Random House, New York, 1989; Biotechnology from A to Z, 2d Edition, William Bains, Oxford University Press, New York, New York, 2002; A Dictionary of Genetics, 6th Edition, Robert C. King and William D. Stansfield, Oxford University Press, New York, New York, 2002; Dorland's Illustrated Medical Dictionary, 29th and 30th Editions, W. B. Saunders Company, Philadelphia, 2000, 2003; Genes VII, Benjamin Lewin, Oxford University Press, New York, New York, 2000; The Gale Encyclopedia of Genetic Disorders, Volumes I and II, Stacey L. Blachford, Ed., Thomson Learning, New York, New York, 2002; The Merriam-Webster Dictionary, Merriam-Webster, Inc., Springfield, Massachusetts, 1997; Molecular Biology of the Cell, 3rd Edition, Bruce Alberts, et al., Garland Publishing, 1994; The Random House Dictionary of the English Language, Unabridged Edition, 1966; Webster's Ninth New Collegiate Dictionary, 1991.
DEFINITION:
- reactive systemic amyloidosis
-
Amyloidosis in which the deposited fibrillar material is of the AA type, and occurs secondary to a chronic infectious process (e.g., tuberculosis and osteomyelitis) or a chronic noninfectious inflammatory disease (e.g., rheumatoid arthritis). It may also occur in association with certain nonlymphoid tumors and some nonimmunoglobulin-producing lymphomas, the two most common being renal cell carcinoma and Hodgkin's disease. Called also secondary amyloidosis .
Used in 1 Term definition
Used in 1 Term definition